Literature DB >> 17085649

Chromosomal instability in microsatellite-unstable and stable colon cancer.

Karolin Trautmann1, Jonathan P Terdiman, Amy J French, Ritu Roydasgupta, Nancy Sein, Sanjay Kakar, Jane Fridlyand, Antoine M Snijders, Donna G Albertson, Stephen N Thibodeau, Frederic M Waldman.   

Abstract

PURPOSE: The genomic instability in colon cancer can be divided into at least two major types, microsatellite instability (MSI) or chromosomal instability (CIN). Although initially felt to be mutually exclusive, recent evidence suggests that there may be overlap between the two. The aim of this study was to identify chromosomal alterations at high resolution in sporadic colon cancers with high-level microsatellite instability (MSI-H) and to compare them to those present in a set of matched microsatellite stable (MSS) tumors. EXPERIMENTAL
DESIGN: Array-based comparative genomic hybridization was used to analyze a set of 23 sporadic MSI-H and 23 MSS colon cancers matched for location, gender, stage, and age. The arrays consisted of 2,464 bacterial artificial chromosome clones.
RESULTS: MSI and MSS colon cancers differed significantly with respect to frequency and type of chromosomal alterations. The median fraction of genome altered was lower among MSI-H tumors than MSS tumors (2.8% versus 30.7%, P=0.00006). However, the MSI-H tumors displayed a range of genomic alterations, from the absence of detectable alterations to extensive alterations. Frequent alterations in MSI-H tumors included gains of chromosomes 8, 12, and 13, and loss of 15q14. In contrast, the most frequent alterations in MSS tumors were gains of 7, 13, 8q, and 20, and losses of 8p, 17p, and 18. A small, previously uncharacterized, genomic deletion on 16p13.2, found in 35% of MSI-H and 21% of MSS tumors, was confirmed by fluorescence in situ hybridization.
CONCLUSION: MSI and CIN are not mutually exclusive forms of genomic instability in sporadic colon cancer, with MSI tumors also showing varying degrees of CIN.

Entities:  

Mesh:

Year:  2006        PMID: 17085649     DOI: 10.1158/1078-0432.CCR-06-1248

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  40 in total

1.  Integrated analysis of genome-wide copy number alterations and gene expression in microsatellite stable, CpG island methylator phenotype-negative colon cancer.

Authors:  Lenora W M Loo; Maarit Tiirikainen; Iona Cheng; Annette Lum-Jones; Ann Seifried; James M Church; Robert Gryfe; Daniel J Weisenberger; Noralane M Lindor; Steven Gallinger; Robert W Haile; David J Duggan; Stephen N Thibodeau; Graham Casey; Loïc Le Marchand
Journal:  Genes Chromosomes Cancer       Date:  2013-01-23       Impact factor: 5.006

2.  Familial colorectal cancer: eleven years of data from a registry program in Switzerland.

Authors:  Michal Kovac; Endre Laczko; Ritva Haider; Josef Jiricny; Hansjakob Mueller; Karl Heinimann; Giancarlo Marra
Journal:  Fam Cancer       Date:  2011-09       Impact factor: 2.375

Review 3.  [Chromosomal instability, microsatellite instability and CpG island methylator phenotype: roles in small intestinal carcinogenesis].

Authors:  H Bläker; A Warth; M Kloor; P Schirmacher
Journal:  Pathologe       Date:  2011-11       Impact factor: 1.011

4.  Molecular patterns in the evolution of serrated lesion of the colorectum.

Authors:  Timo Gaiser; Sandra Meinhardt; Daniela Hirsch; Jonathan Keith Killian; Jochen Gaedcke; Peter Jo; Immaculada Ponsa; Rosa Miró; Josef Rüschoff; Gerhard Seitz; Yue Hu; Jordi Camps; Thomas Ried
Journal:  Int J Cancer       Date:  2012-10-17       Impact factor: 7.396

5.  Improved testing for microsatellite instability in colorectal cancer using a simplified 3-marker assay.

Authors:  Iyare Esemuede; Ann Forslund; Sajid A Khan; Li-Xuan Qin; Mark I Gimbel; Garrett M Nash; Zhaoshi Zeng; Shoshana Rosenberg; Jinru Shia; Francis Barany; Philip B Paty
Journal:  Ann Surg Oncol       Date:  2010-08-12       Impact factor: 5.344

6.  CpG island methylator phenotype associates with low-degree chromosomal abnormalities in colorectal cancer.

Authors:  Yu-Wei Cheng; Hanna Pincas; Manny D Bacolod; Gunter Schemmann; Sarah F Giardina; Jianmin Huang; Sandra Barral; Kamran Idrees; Sajid A Khan; Zhaoshi Zeng; Shoshana Rosenberg; Daniel A Notterman; Jurg Ott; Philip Paty; Francis Barany
Journal:  Clin Cancer Res       Date:  2008-10-01       Impact factor: 12.531

7.  Early onset MSI-H colon cancer with MLH1 promoter methylation, is there a genetic predisposition?

Authors:  Eddy H J van Roon; Marjo van Puijenbroek; Anneke Middeldorp; Ronald van Eijk; Emile J de Meijer; Dianhdra Erasmus; Kim A D Wouters; Manon van Engeland; Jan Oosting; Frederik J Hes; Carli M J Tops; Tom van Wezel; Judith M Boer; Hans Morreau
Journal:  BMC Cancer       Date:  2010-05-05       Impact factor: 4.430

8.  Distinct genetic alterations in colorectal cancer.

Authors:  Hassan Ashktorab; Alejandro A Schäffer; Mohammad Daremipouran; Duane T Smoot; Edward Lee; Hassan Brim
Journal:  PLoS One       Date:  2010-01-26       Impact factor: 3.240

Review 9.  High throughput molecular diagnostics in bladder cancer - on the brink of clinical utility.

Authors:  Karsten Zieger
Journal:  Mol Oncol       Date:  2007-12-08       Impact factor: 6.603

10.  Genome-wide copy neutral LOH is infrequent in familial and sporadic microsatellite unstable carcinomas.

Authors:  Marjo van Puijenbroek; Anneke Middeldorp; Carli M J Tops; Ronald van Eijk; Heleen M van der Klift; Hans F A Vasen; Juul Th Wijnen; Frederik J Hes; Jan Oosting; Tom van Wezel; Hans Morreau
Journal:  Fam Cancer       Date:  2008-04-15       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.